COMP <GO>
PRGO vs AGIO // EV/EBITDA & P/E VALUATION
Perrigo Company plc (NYSE) VS. Agios Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: PRGO 7
— AGIO 4
■ METRIC PARITY
LAST: $15.90 (-0.13%) • MKT CAP: $2.21B
valuation
—
LAST: $37.23 (-2.33%) • MKT CAP: $2.22B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRGO VS. AGIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRGO | AGIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.10% | 88.30% | -53.20 | AGIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.60% | -33.80% | +20.20 | PRGO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | -16.97% | +23.55 | PRGO | /fcf-yield <GO> |
| Operating Margin | -26.40% | -60.00% | +33.60 | PRGO | /operating-margins <GO> |
| Net Profit Margin | -33.50% | -60.00% | +26.50 | PRGO | /net-margins <GO> |
| Revenue Growth (YoY) | -2.80% | 48.00% | -50.80 | AGIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.22% | 0.00% | +7.22 | PRGO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 11.84 | -11.64 | AGIO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | PRGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.3 | 37.2 | +18.02 | PRGO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.21B | $2.22B | -$16.3M | AGIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRGO REV | AGIO REV | PRGO GROSS % | AGIO GROSS % | PRGO FCF | AGIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.25B | $54.0M | 35.1% | 88.3% | $145.1M | -$377.3M |
| FY 2024 | $4.37B | $36.5M | 35.3% | 88.6% | $244.6M | -$391.5M |
| FY 2023 | $4.66B | $26.8M | — | — | $405.5M | -$296.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRGO // BETA —
AGIO // BETA —